We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
Cap. Flow
-$1.04B
Cap. Flow %
-2.01%
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
XL
XL Group Ltd.
XL
+$28.4M
3
MSFT icon
Microsoft
MSFT
+$26.9M
4
CSCO icon
Cisco
CSCO
+$24.2M
5
GGP
GGP Inc.
GGP
+$24M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Financials 15.87%
3 Healthcare 13.94%
4 Consumer Discretionary 10.36%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBPX
1901
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$1.25M ﹤0.01%
33,189
-2,362
-7% -$84K
MCRI icon
1902
Monarch Casino & Resort
MCRI
$2.19B
$1.25M ﹤0.01%
27,384
-148
-0.5% -$6.88K
CNS icon
1903
Cohen & Steers
CNS
$4.34B
$1.24M ﹤0.01%
30,451
-1,450
-5% -$60.8K
EFSC icon
1904
Enterprise Financial Services Corp
EFSC
$2.4B
$1.24M ﹤0.01%
23,324
-400
-2% -$22.3K
PGNX
1905
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.24M ﹤0.01%
197,251
+17,537
+10% +$135K
AVD icon
1906
American Vanguard Corp
AVD
$73.5M
$1.23M ﹤0.01%
68,374
-486
-0.7% -$10.1K
WLH
1907
DELISTED
WILLIAM LYON HOMES
WLH
$1.23M ﹤0.01%
77,278
+5,507
+8% +$115K
EHTH icon
1908
eHealth
EHTH
$42.9M
$1.23M ﹤0.01%
43,418
-213
-0.5% -$5.66K
BANF icon
1909
BancFirst
BANF
$3.81B
$1.22M ﹤0.01%
20,422
-186
-0.9% -$11.6K
IMAX icon
1910
IMAX
IMAX
$2.73B
$1.22M ﹤0.01%
47,403
-4,100
-8% -$96.5K
HAPN
1911
Happen Inc
HAPN
$2.27B
$1.22M ﹤0.01%
62,919
-10
-0% -$194
CYTK icon
1912
Cytokinetics
CYTK
$11B
$1.22M ﹤0.01%
123,865
+4,035
+3% +$32.4K
CWST icon
1913
Casella Waste Systems
CWST
$5.75B
$1.22M ﹤0.01%
39,221
-425
-1% -$12.1K
PBYI icon
1914
Puma Biotechnology
PBYI
$413M
$1.22M ﹤0.01%
26,553
-1,741
-6% -$83.9K
RUN icon
1915
Sunrun
RUN
$2.24B
$1.21M ﹤0.01%
97,254
+1,320
+1% +$18.3K
TBPH icon
1916
Theravance Biopharma
TBPH
$877M
$1.21M ﹤0.01%
37,031
-2,750
-7% -$74.9K
VECO icon
1917
Veeco
VECO
$3.15B
$1.21M ﹤0.01%
117,780
-750
-0.6% -$9.38K
HRI icon
1918
Herc Holdings
HRI
$5.62B
$1.2M ﹤0.01%
23,506
-1,575
-6% -$85.2K
CLW icon
1919
Clearwater Paper
CLW
$369M
$1.2M ﹤0.01%
40,494
-557
-1% -$15K
IVC
1920
DELISTED
Invacare Corporation
IVC
$1.2M ﹤0.01%
82,667
-53
-0.1% -$878
ATSG
1921
DELISTED
Air Transport Services Group
ATSG
$1.2M ﹤0.01%
55,833
-3,536
-6% -$77.1K
HURN icon
1922
Huron Consulting
HURN
$2.39B
$1.2M ﹤0.01%
24,237
+135
+0.6% +$6.31K
RPD icon
1923
Rapid7
RPD
$694M
$1.2M ﹤0.01%
32,378
-1,971
-6% -$66.2K
CATO icon
1924
Cato Corp
CATO
$65.9M
$1.19M ﹤0.01%
56,787
-95
-0.2% -$2.2K
IMGN
1925
DELISTED
Immunogen Inc
IMGN
$1.19M ﹤0.01%
126,034
+801
+0.6% +$7.7K

Similar funds

RhumbLine Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
  • RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
  • RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
  • RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
  • RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
  • RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.